Rates and probabilities in economic modelling: Transformation, translation and appropriate application

PharmacoEconomics

Volumn 25, Issue 1, 2007, Pages 3-6

  Fleurence, Rachael L ^a   Hollenbeak, Christopher S ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; MATHEMATICAL COMPUTING; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PROBABILITY; RATING SCALE; REVIEW; STATISTICAL MODEL;

EID: 33846118263     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200725010-00002     Document Type: Review

References (11)

1. Neumann PJ. Evidence-based and value-based formulary guidelines. Health Aff (Millwood) 2004; 23 (1): 124-34
2. Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application. Pharmacoeconomics 2000; 17 (5): 461-77
3. Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997; 6 (3): 217-27
4. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998; 13 (4): 397-409
5. Philips Z, Ginnelly L, Sculpher M, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004; 8 (36): 1-172
6. Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices. Modeling studies. Value Health 2003; 6 (1): 9-17
7. Miller DK, Homan SM. Determining transition probabilities: confusion and suggestions. Med Decis Making 1994; 14: 52-8
8. Hennekens C, Buring J. Epidemiology in medicine. Toronto (ON): Little Brown and Co., 1987
9. Myers ER, McCrory DC, Nanda K, et al. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000; 151 (12): 1158-71
10. Hunink M, Glasziou P, Siegel J, et al. Decision making in health and medicine: integrating evidence and values. New York: Cambridge University Press, 2001
11. Welton NJ, Ades AE. Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration. Med Decis Making 2005; 25 (6): 633-45